WAYRILZ: payments to doctors
Payments that named WAYRILZ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $541K
- Providers
- 2,277
- Transactions
- 2,915
- Average per transaction
- $186
The per-transaction average — $186 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,277 providers the average total is $238, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $532,503 | 98.4% |
| Sanofi US Services Inc. | $5,196 | 1.0% |
| Sanofi Pasteur Inc. | $3,466 | 0.6% |